Showing results (381-390 of 388) with videos related to
Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 388 results.
The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.Trials|October 24, 2023
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorderOrli S Schwartz, Paul Amminger, Bernard T Baune, et al.Plos One|August 1, 2022
Aedes koreicus, a vector on the rise: Pan-European genetic patterns, mitochondrial and draft genome sequencingKornélia Kurucz, Safia Zeghbib, Daniele Arnoldi, et al.Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.Clinical Pharmacology and Therapeutics|January 2, 2021
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid TherapyKristine R Crews, Andrew A Monte, Rachel Huddart, et al.Nature Communications|April 1, 2022
Isolation of infectious Lloviu virus from Schreiber's bats in HungaryGábor Kemenesi, Gábor E Tóth, Martin Mayora-Neto, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 17, 2012
Opioid activation of toll-like receptor 4 contributes to drug reinforcementM R Hutchinson, A L Northcutt, T Hiranita, et al.The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.Pageof 39